DeSantis, Republicans cry foul over FDA’s monoclonal antibody decision


Five out of six clinical antibodies that lost antiviral activity (Bamlanivimab, Etesevimab, Casirivimab, Imdevimab and Regdanvimab) no longer recognized Omicron infected cells. The other antibodies still bound to Omicron-infected cell.

We report that among nine [monoclonal antibodies] in clinical use or in development, six (Bamlanivimab, Etesevimab, Casirivimab, Imdevimab, Tixagevimab and Regdanvimab) were inactive against Omicron.

Source link

Leave A Reply

Your email address will not be published.